FDA grants traditional approval to tepotinib for MET exon 14 NSCLCNov 9Regulatory decisionMerck KGaAtepotinib
Bio-Techne declares quarterly dividend contingent on Merck KGaA deal timingNov 3PeopleBIO-TECHNE CorpMerck KGaA
Adlai Nortye signs trial deals with Lilly, Merck KGaA for AN4035-cetuximab studyOct 15PartnershipAdlai Nortye Group Ltd.cetuximab
Merck KGaA registers Elowen-LTE Phase 3 lupus study and mirdametinib drug interaction trialSep 25Weekly roundup, 2 itemsMerck KGaAmirdametinib
Bio-Techne adds proxy disclosures ahead of Merck KGaA merger vote amid shareholder suitSep 14M&ABIO-TECHNE CorpMerck KGaA
JAVELIN Bladder Medley results posted; Merck files separate MK-2010 trial across six tumor typesSep 1Weekly roundup, 2 itemsavelumabbelzutifan